Search

Your search keyword '"Shan Cen"' showing total 369 results

Search Constraints

Start Over You searched for: Author "Shan Cen" Remove constraint Author: "Shan Cen"
369 results on '"Shan Cen"'

Search Results

101. COVID-19 reinfection in the presence of neutralizing antibodies

102. Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C

103. 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis

104. Daldispones A and B, two new cyclopentenones from Daldinia sp. CPCC 400770

106. Interferon-Stimulated SAMHD1 Restricts Hepatitis C Virus Replication

107. Progress of SLFN family proteins in tumor and virus infection

108. 2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action

109. Design, synthesis and in vitro anti-influenza A virus evaluation of novel quinazoline derivatives containing S-acetamide and NH-acetamide moieties at C-4

110. Novel HIV-1 Protease Inhibitors with Morpholine as the P2 Ligand to Enhance Activity against DRV-Resistant Variants

111. Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives

112. Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study

113. Anthraquinone analogues with inhibitory activities against influenza a virus from Polygonatum odoratum

114. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus

115. PKR-dependent cytosolic cGAS foci are necessary for intracellular DNA sensing

116. Study of Serum CD147 Level in Patients with Transient Ischemic Attack and CD147 Expression in Atherosclerotic Plaque

117. Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein

118. Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation

119. Mast cells-derived exosomes worsen the development of experimental cerebral malaria

120. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors

121. Non-volatile acylphloroglucinol components from Eucalyptus robusta inhibit Zika virus by impairing RdRp activity of NS5

122. Design and biological evaluation of cinnamic and phenylpropionic amide derivatives as novel dual inhibitors of HIV-1 protease and reverse transcriptase

123. Dengratiols A–D, four new bibenzyl derivatives from Dendrobium gratiossimum

124. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase

125. Identification and characterization of loop7 motif and its role in regulating biological function of human APOBEC3G through molecular modeling and biological assay

126. Anti-influenza triterpenoid saponins (saikosaponins) from the roots of Bupleurum marginatum var. stenophyllum

127. Broad-Spectrum Antiviral Natural Products from the Marine-Derived Penicillium sp. IMB17-046

128. Identification of a Type-Specific Promoter Element That Differentiates between Influenza A and B Viruses

129. High-throughput screening of active compounds against human respiratory syncytial virus

130. Synthesis and biological evaluation of new HIV-1 protease inhibitors with purine bases as P2-ligands

131. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity

132. HIV-1 Antisense Protein of Different Clades Induces Autophagy and Associates with the Autophagy Factor p62

133. Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses

134. An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers

135. Human MxB Inhibits the Replication of Hepatitis C Virus

136. Synthesis and biological evaluation of substituted indole and its analogs as influenza A virus inhibitors

137. Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants

138. Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents

139. Citron kinase enhances ubiquitination of HIV-1 Gag protein and intracellular HIV-1 budding

140. CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape

141. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16

142. Steroidal glycosides, homoisoflavanones and cinnamic acid derivatives from Polygonatum odoratum and their inhibitory effects against influenza A virus

143. Design and biological evaluation of novel HIV-1 protease inhibitors with isopropanol as P1′ ligand to enhance binding with S1′ subsite

144. Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors

145. Rational design and Structure−Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase

146. Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A

147. Screening of kinase inhibitors downregulating PD-L1 expression via on/in cell quantitative immunoblots

148. MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein

149. [Molecular mechanisms of genetic transposition inhibition by piRNA]

150. [The sensitivity of transmitted/founder HIV-1 to anti-HIV drugs]

Catalog

Books, media, physical & digital resources